Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 162

    1.

    Molecular prognostic markers for adult acute myeloid leukemia with normal cytogenetics.

    Gregory TK, Wald D, Chen Y, Vermaat JM, Xiong Y, Tse W.

    J Hematol Oncol. 2009 Jun 2;2:23. Review.

    PMID:
    19490647
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Genetic abnormalities in acute myelogenous leukemia with normal cytogenetics.

    Wald D, Vermaat JM, Peleg G, Tse W.

    Curr Hematol Malig Rep. 2008 Apr;3(2):83-8.

    PMID:
    20425451
    [PubMed - indexed for MEDLINE]
    3.

    Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.

    Marcucci G, Maharry K, Radmacher MD, Mrózek K, Vukosavljevic T, Paschka P, Whitman SP, Langer C, Baldus CD, Liu CG, Ruppert AS, Powell BL, Carroll AJ, Caligiuri MA, Kolitz JE, Larson RA, Bloomfield CD.

    J Clin Oncol. 2008 Nov 1;26(31):5078-87. Epub 2008 Sep 22. Erratum in: J Clin Oncol. 2008 Dec 20;26(36):6021.

    PMID:
    18809607
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Molecular heterogeneity and prognostic biomarkers in adults with acute myeloid leukemia and normal cytogenetics.

    Marcucci G, Mrózek K, Bloomfield CD.

    Curr Opin Hematol. 2005 Jan;12(1):68-75. Review.

    PMID:
    15604894
    [PubMed - indexed for MEDLINE]
    5.

    The challenge of risk stratification in acute myeloid leukemia with normal karyotype.

    Zaidi SZ, Owaidah T, Al Sharif F, Ahmed SY, Chaudhri N, Aljurf M.

    Hematol Oncol Stem Cell Ther. 2008 Jul-Sep;1(3):141-58. Review.

    PMID:
    20063545
    [PubMed - indexed for MEDLINE]
    6.

    Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogenetics.

    Strunk CJ, Platzbecker U, Thiede C, Schaich M, Illmer T, Kang Z, Leahy P, Li C, Xie X, Laughlin MJ, Lazarus HM, Gerson SL, Bunting KD, Ehninger G, Tse W.

    Am J Hematol. 2009 May;84(5):308-9.

    PMID:
    19396856
    [PubMed - indexed for MEDLINE]
    7.

    Acute myeloid leukemia with biallelic CEBPA gene mutations and normal karyotype represents a distinct genetic entity associated with a favorable clinical outcome.

    Dufour A, Schneider F, Metzeler KH, Hoster E, Schneider S, Zellmeier E, Benthaus T, Sauerland MC, Berdel WE, Büchner T, Wörmann B, Braess J, Hiddemann W, Bohlander SK, Spiekermann K.

    J Clin Oncol. 2010 Feb 1;28(4):570-7. Epub 2009 Dec 28.

    PMID:
    20038735
    [PubMed - indexed for MEDLINE]
    8.

    Single nucleotide polymorphism in the mutational hotspot of WT1 predicts a favorable outcome in patients with cytogenetically normal acute myeloid leukemia.

    Damm F, Heuser M, Morgan M, Yun H, Grosshennig A, Göhring G, Schlegelberger B, Döhner K, Ottmann O, Lübbert M, Heit W, Kanz L, Schlimok G, Raghavachar A, Fiedler W, Kirchner H, Döhner H, Heil G, Ganser A, Krauter J.

    J Clin Oncol. 2010 Feb 1;28(4):578-85. Epub 2009 Dec 28.

    PMID:
    20038731
    [PubMed - indexed for MEDLINE]
    9.

    Prognostic importance of MN1 transcript levels, and biologic insights from MN1-associated gene and microRNA expression signatures in cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

    Langer C, Marcucci G, Holland KB, Radmacher MD, Maharry K, Paschka P, Whitman SP, Mrózek K, Baldus CD, Vij R, Powell BL, Carroll AJ, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD.

    J Clin Oncol. 2009 Jul 1;27(19):3198-204. Epub 2009 May 18.

    PMID:
    19451432
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    10.

    Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.

    Baldus CD, Mrózek K, Marcucci G, Bloomfield CD.

    Br J Haematol. 2007 Jun;137(5):387-400. Review.

    PMID:
    17488484
    [PubMed - indexed for MEDLINE]
    11.

    Prognostically important molecular markers in cytogenetically normal acute myeloid leukemia.

    Lin TL, Smith BD.

    Am J Med Sci. 2011 May;341(5):404-8. Review.

    PMID:
    21522052
    [PubMed - indexed for MEDLINE]
    12.

    ERG expression is an independent prognostic factor and allows refined risk stratification in cytogenetically normal acute myeloid leukemia: a comprehensive analysis of ERG, MN1, and BAALC transcript levels using oligonucleotide microarrays.

    Metzeler KH, Dufour A, Benthaus T, Hummel M, Sauerland MC, Heinecke A, Berdel WE, Büchner T, Wörmann B, Mansmann U, Braess J, Spiekermann K, Hiddemann W, Buske C, Bohlander SK.

    J Clin Oncol. 2009 Oct 20;27(30):5031-8. Epub 2009 Sep 14.

    PMID:
    19752345
    [PubMed - indexed for MEDLINE]
    13.

    Wilms' tumor 1 gene mutations independently predict poor outcome in adults with cytogenetically normal acute myeloid leukemia: a cancer and leukemia group B study.

    Paschka P, Marcucci G, Ruppert AS, Whitman SP, Mrózek K, Maharry K, Langer C, Baldus CD, Zhao W, Powell BL, Baer MR, Carroll AJ, Caligiuri MA, Kolitz JE, Larson RA, Bloomfield CD.

    J Clin Oncol. 2008 Oct 1;26(28):4595-602. Epub 2008 Jun 16.

    PMID:
    18559874
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    14.

    Prognostic implications of gene mutations in acute myeloid leukemia with normal cytogenetics.

    Gaidzik V, Döhner K.

    Semin Oncol. 2008 Aug;35(4):346-55. Review.

    PMID:
    18692685
    [PubMed - indexed for MEDLINE]
    15.

    High expression levels of the ETS-related gene, ERG, predict adverse outcome and improve molecular risk-based classification of cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B Study.

    Marcucci G, Maharry K, Whitman SP, Vukosavljevic T, Paschka P, Langer C, Mrózek K, Baldus CD, Carroll AJ, Powell BL, Kolitz JE, Larson RA, Bloomfield CD; Cancer and Leukemia Group B Study.

    J Clin Oncol. 2007 Aug 1;25(22):3337-43. Epub 2007 Jun 18.

    PMID:
    17577018
    [PubMed - indexed for MEDLINE]
    16.

    Risk assessment in patients with acute myeloid leukemia and a normal karyotype.

    Bienz M, Ludwig M, Leibundgut EO, Mueller BU, Ratschiller D, Solenthaler M, Fey MF, Pabst T.

    Clin Cancer Res. 2005 Feb 15;11(4):1416-24. Erratum in: Clin Cancer Res. 2005 Aug 1;11(15):5659.

    PMID:
    15746041
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Presence of FLT3-ITD and high BAALC expression are independent prognostic markers in childhood acute myeloid leukemia.

    Staffas A, Kanduri M, Hovland R, Rosenquist R, Ommen HB, Abrahamsson J, Forestier E, Jahnukainen K, Jónsson ÓG, Zeller B, Palle J, Lönnerholm G, Hasle H, Palmqvist L, Ehrencrona H; Nordic Society of Pediatric Hematology and Oncology (NOPHO).

    Blood. 2011 Nov 24;118(22):5905-13. Epub 2011 Oct 3.

    PMID:
    21967978
    [PubMed - indexed for MEDLINE]
    18.

    Prognostic significance of CEBPA mutations and BAALC expression in acute myeloid leukemia Egyptian patients with normal karyotype.

    El-Sharnouby JA, Ahmed LM, Taha AM, Kamal O.

    Egypt J Immunol. 2008;15(1):131-43.

    PMID:
    20306678
    [PubMed - indexed for MEDLINE]
    19.

    Multilineage dysplasia has no impact on biologic, clinicopathologic, and prognostic features of AML with mutated nucleophosmin (NPM1).

    Falini B, Macijewski K, Weiss T, Bacher U, Schnittger S, Kern W, Kohlmann A, Klein HU, Vignetti M, Piciocchi A, Fazi P, Martelli MP, Vitale A, Pileri S, Miesner M, Santucci A, Haferlach C, Mandelli F, Haferlach T.

    Blood. 2010 May 6;115(18):3776-86. Epub 2010 Mar 4. Erratum in: Blood. 2010 Aug 12;116(6):1017.

    PMID:
    20203266
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    AML with mutated NPM1 carrying a normal or aberrant karyotype show overlapping biologic, pathologic, immunophenotypic, and prognostic features.

    Haferlach C, Mecucci C, Schnittger S, Kohlmann A, Mancini M, Cuneo A, Testoni N, Rege-Cambrin G, Santucci A, Vignetti M, Fazi P, Martelli MP, Haferlach T, Falini B.

    Blood. 2009 Oct 1;114(14):3024-32. Epub 2009 May 8.

    PMID:
    19429869
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk